Braintree Loses Bid To Toss MiraLax Antitrust Suit
A federal judge on Wednesday refused to dismiss a class action alleging that Braintree Laboratories Inc., which manufactures constipation drug MiraLax, violated antitrust laws by initiating sham litigation against a company...To view the full article, register now.
Already a subscriber? Click here to view full article